Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells
- 1 July 1995
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 60 (1-2) , 9-15
- https://doi.org/10.1016/0165-5728(95)00047-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- Increases levels of circulating intercellular adhesion molecule‐1 in multiple sclerosis and human T‐lymphotropic virus type I‐associated myelopathyAnnals of Neurology, 1993
- Expression of intercellular adhesion molecule-1 on rat microglial cellsNeuroscience Letters, 1993
- Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.The Journal of Experimental Medicine, 1993
- Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.The Journal of Experimental Medicine, 1993
- Adhesion of Cerebral Endothelial Cells to Lymphocytes from Patients with Multiple SclerosisAutoimmunity, 1993
- Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cellsBiochemical and Biophysical Research Communications, 1992
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- MS: a CNS and systematic autoimmune diseaseImmunology Today, 1989